Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A frontotemporal dementia–like phenotype in schizophrenia: links to striatal dopamine and iron accumulation
    Published on 2026-04-25
    5 months ago
  • A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study
    Published on 2026-04-24
    5 months ago
  • Adolescent obesity induces sex-specific alterations of action control
    Published on 2026-04-23
    5 months ago
  • Neural response to reward uncertainty in adolescents with mood and anxiety symptoms
    Published on 2026-04-23
    5 months ago
  • William H. Morse (1928–2026)
    Published on 2026-04-22
    5 months ago
  • Target engagement in a head-to-head clinical trial of dysphoric versus anxiosomatic transcranial magnetic stimulation targets
    Published on 2026-04-22
    5 months ago
  • Nucleus accumbens neuron subtype translatome signatures in socially stressed females
    Published on 2026-04-22
    5 months ago
« Previous 1 … 19 20 21 22 23 … 143 Next »
Journal of Psychopharmacology
  • Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review
    Published on 2025-12-13
    9 months ago
  • Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review
    Published on 2025-12-05
    9 months ago
  • Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
    Published on 2025-12-04
    9 months ago
  • The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications
    Published on 2025-12-02
    9 months ago
  • The role of psychopharmacology and cognitive neuroscience in understanding the brain in the treatment of psychiatric disorders and neurological diseases for the benefit of society
    Published on 2025-12-01
    10 months ago
  • “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS
    Published on 2025-12-01
    10 months ago
  • A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia
    Published on 2025-12-01
    10 months ago
« Previous 1 … 19 20 21 22 23 … 154 Next »
European Neuropsychopharmacology
  • Response to Commentaries on Article: “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”
    Published on 2025-09-23
    12 months ago
  • Machine learning and neuroimaging in mood disorders: A promising path forward
    Published on 2025-09-23
    12 months ago
  • Comment on “Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction”
    Published on 2025-09-23
    12 months ago
  • Response to the letter to the editor: “Compressed design, inflated conclusions? A cautionary note on vaporized DMT trials”
    Published on 2025-09-23
    12 months ago
  • Single-cell atlas of schizophrenia peripheral immunity implicates neutrophil-driven inflammation and adaptive immune suppression
    Published on 2025-09-23
    12 months ago
  • Reply from the Authors
    Published on 2025-09-22
    12 months ago
  • Esketamine in bipolar depression: Are we overlooking critical subgroups and dosing details?
    Published on 2025-09-22
    12 months ago
« Previous 1 … 19 20 21 22 23 … 170 Next »

   Pharma Pub